GLUE is Monte Rosa Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $13.84. Market cap: $1.18B. Capital Quality Rank: 46/100 — Stagnant mediocrity.
Stock snapshot
| Price | $13.84 |
| Market cap | $1.18B |
| Sector | Healthcare |
| Exchange | NMS |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 46 / 100 · Stagnant mediocrity |
| ROIC (TTM) | -41.5% |
| Shareholder buyback yield | -11.03% |
| Altman Z-score zone | Grey |
About GLUE
Monte Rosa Therapeutics Inc is a clinical-stage biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. The company has three programs in clinical development: MRT-6160, a VAV1-directed MGD for immune-mediated diseases; MRT-8102, a NEK7-directed MGD for inflammatory diseases driven by IL-6, and the NLRP3 inflammasome; and MRT-2359, a GSPT1-directed MGD for metastatic castration resistant prostate cancer (mCRPC).
Related non-dividend companies
Other non-dividend stocks investors research alongside GLUE. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is GLUE's current stock price?
GLUE (Monte Rosa Therapeutics, Inc.) is currently trading at $13.84.
Does GLUE pay a dividend?
GLUE (Monte Rosa Therapeutics, Inc.) does not currently pay a regular dividend.
What is GLUE's Capital Quality Rank?
GLUE has a Capital Quality Rank of 46/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track GLUE in DiviDrip
Add GLUE to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search GLUE and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-06. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.